Literature DB >> 28197633

PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells.

Amany Sayed Mawas1, Vishwa Jeet Amatya1, Rui Suzuki1, Kei Kushitani1, Mouchira M Mohi El-Din2, Yukio Takeshima1.   

Abstract

Malignant mesothelioma is a major asbestos-related cancer with prolonged time lapse from the first exposure of asbestos to the development of mesothelioma. Most of mesothelioma patients show very poor prognosis, thus, an urgent improvement of its treatment is required by development of novel therapeutic strategies. RNA interference (RNAi) is a powerful tool in post-genomic research and cancer therapy through inhibition of gene expression. In the present study, we analyzed the function of PIM1 on mesothelioma cell lines with its knockdown by siRNA transfection. Here, we report that the downregulation of PIM1 led to suppression of cell proliferation by cell cycle arrest at G1 phase and suppression of cell invasion and migration. Considering the mesothelioma as rapidly growing invasive cancer, downregulation of PIM1 may have a potential role for therapeutic management of malignant mesothelioma.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28197633     DOI: 10.3892/ijo.2017.3863

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  Inhibition of miR-18a-3p reduces proliferation of mesothelioma cells and sensitizes them to cisplatin.

Authors:  Rui Suzuki; Vishwa Jeet Amatya; Kei Kushitani; Yuichiro Kai; Takahiro Kambara; Yutaro Fujii; Yukio Takeshima
Journal:  Oncol Lett       Date:  2020-04-01       Impact factor: 2.967

2.  Epstein-Barr virus-encoded LMP1 regulated Pim1 kinase expression promotes nasopharyngeal carcinoma cells proliferation.

Authors:  Ran-Ran Ding; Jian-Ling Yuan; Ya-Nan Jia; Xiao-Min Liao; Si-Si Wang; Zhong-Ming Shao; Mu-Yin Feng; Wei Jie; Zhi-Hua Shen
Journal:  Onco Targets Ther       Date:  2019-02-11       Impact factor: 4.147

3.  miR24-2 accelerates progression of liver cancer cells by activating Pim1 through tri-methylation of Histone H3 on the ninth lysine.

Authors:  Yuxin Yang; Shuting Song; Qiuyu Meng; Liyan Wang; Xiaonan Li; Sijie Xie; Yingjie Chen; Xiaoxue Jiang; Chen Wang; Yanan Lu; Xiaoru Xin; Hu Pu; Xin Gui; Tianming Li; Jie Xu; Jiao Li; Song Jia; Dongdong Lu
Journal:  J Cell Mol Med       Date:  2020-02-06       Impact factor: 5.310

4.  Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1.

Authors:  Ying Liu; Dao-Hai Cheng; Ke-Dao Lai; Hua Su; Guo-Shou Lu; Li Wang; Ji-Hua Lv
Journal:  Drug Des Devel Ther       Date:  2021-12-01       Impact factor: 4.162

Review 5.  Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma.

Authors:  Kimberly A Birnie; Cecilia M Prêle; Philip J Thompson; Bahareh Badrian; Steven E Mutsaers
Journal:  Oncotarget       Date:  2017-08-24

6.  PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis.

Authors:  Bin Zhao; Lei Liu; Jun Mao; Zhiwei Zhang; Qifei Wang; Quanlin Li
Journal:  Cell Death Dis       Date:  2018-02-22       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.